Annual ROE
8.03%
+12.73%+270.85%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual return on equity is currently 8.03%, with the most recent change of +12.73% (+270.85%) on 31 December 2023. During the last 3 years, it has risen by +8.43% (+2107.50%). LGND annual ROE is now -99.20% below its all-time high of 997.71%, reached on 31 December 2007.LGND ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
5.97%
+0.14%+2.40%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly return on equity is currently 5.97%, with the most recent change of +0.14% (+2.40%) on 30 September 2024. Over the past year, it has increased by +3.54% (+145.68%). LGND quarterly ROE is now -99.89% below its all-time high of 5291.62%, reached on 30 September 2010.LGND Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +270.9% | +145.7% |
| 3 y3 years | +2107.5% | -34.4% |
| 5 y5 years | -72.6% | -91.5% |
LGND ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +270.9% | -56.8% | +237.2% |
| 5 y | 5 years | -91.5% | +270.9% | -91.8% | +185.9% |
| alltime | all time | -99.2% | +100.8% | -99.9% | +100.2% |
Ligand Pharmaceuticals Incorporated ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 5.97%(+2.4%) |
| June 2024 | - | 5.83%(-57.8%) |
| Mar 2024 | - | 13.82%(+73.6%) |
| Dec 2023 | 8.03%(-270.9%) | 7.96%(+227.6%) |
| Sept 2023 | - | 2.43%(-36.9%) |
| June 2023 | - | 3.85%(+17.4%) |
| Mar 2023 | - | 3.28%(-175.4%) |
| Dec 2022 | -4.70%(-162.9%) | -4.35%(+65.4%) |
| Sept 2022 | - | -2.63%(+165.7%) |
| June 2022 | - | -0.99%(-133.1%) |
| Mar 2022 | - | 2.99%(-59.4%) |
| Dec 2021 | 7.47%(-1967.5%) | 7.37%(-19.0%) |
| Sept 2021 | - | 9.10%(+38.1%) |
| June 2021 | - | 6.59%(+17.9%) |
| Mar 2021 | - | 5.59%(-1431.0%) |
| Dec 2020 | -0.40%(-100.4%) | -0.42%(-80.8%) |
| Sept 2020 | - | -2.19%(-28.7%) |
| June 2020 | - | -3.07%(-55.8%) |
| Mar 2020 | - | -6.95%(-109.5%) |
| Dec 2019 | 94.76%(+223.9%) | 73.17%(+4.2%) |
| Sept 2019 | - | 70.19%(-17.0%) |
| June 2019 | - | 84.56%(-23.5%) |
| Mar 2019 | - | 110.54%(+331.3%) |
| Dec 2018 | 29.26%(+820.1%) | 25.63%(-23.7%) |
| Sept 2018 | - | 33.61%(+32.9%) |
| June 2018 | - | 25.29%(+105.9%) |
| Mar 2018 | - | 12.28%(+296.1%) |
| Dec 2017 | 3.18%(-723.5%) | 3.10%(-25.5%) |
| Sept 2017 | - | 4.16%(+78.5%) |
| June 2017 | - | 2.33%(-384.1%) |
| Mar 2017 | - | -0.82%(+82.2%) |
| Dec 2016 | -0.51%(-100.3%) | -0.45%(-119.8%) |
| Sept 2016 | - | 2.27%(-96.9%) |
| June 2016 | - | 72.41%(-34.7%) |
| Mar 2016 | - | 110.90%(-32.9%) |
| Dec 2015 | 152.55%(+369.5%) | 165.35%(-33.9%) |
| Sept 2015 | - | 250.14%(+255.0%) |
| June 2015 | - | 70.46%(+200.3%) |
| Mar 2015 | - | 23.46%(-4.4%) |
| Dec 2014 | 32.49%(+8.3%) | 24.55%(+90.5%) |
| Sept 2014 | - | 12.89%(-10.3%) |
| June 2014 | - | 14.37%(-45.2%) |
| Mar 2014 | - | 26.22%(-12.4%) |
| Dec 2013 | 30.01%(-1087.2%) | 29.93%(-8.4%) |
| Sept 2013 | - | 32.68%(+5.1%) |
| June 2013 | - | 31.08%(-4477.5%) |
| Mar 2013 | - | -0.71%(-74.8%) |
| Dec 2012 | -3.04%(-100.5%) | -2.82%(-112.7%) |
| Sept 2012 | - | 22.28%(-368.8%) |
| June 2012 | - | -8.29%(-154.6%) |
| Mar 2012 | - | 15.19%(-95.0%) |
| Dec 2011 | 582.43%(+172.3%) | 302.73%(-37.6%) |
| Sept 2011 | - | 485.26%(-357.4%) |
| June 2011 | - | -188.52%(+55.9%) |
| Mar 2011 | - | -120.89%(-127.6%) |
| Dec 2010 | 213.92%(-511.1%) | 437.31%(-91.7%) |
| Sept 2010 | - | 5291.62%(-797.3%) |
| June 2010 | - | -758.82%(+7051.9%) |
| Mar 2010 | - | -10.61%(-144.6%) |
| Dec 2009 | -52.03% | 23.78%(-96.3%) |
| Sept 2009 | - | 637.42%(-40.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | 1069.17%(-144.0%) |
| Mar 2009 | - | -2428.27%(+218.1%) |
| Dec 2008 | -1046.55%(-204.9%) | -763.43%(+583.3%) |
| Sept 2008 | - | -111.72%(+837.2%) |
| June 2008 | - | -11.92%(-227.6%) |
| Mar 2008 | - | 9.34%(-98.8%) |
| Dec 2007 | 997.71%(-959.7%) | 754.24%(-34.3%) |
| Sept 2007 | - | 1148.47%(-194.7%) |
| June 2007 | - | -1213.11%(+219.1%) |
| Mar 2007 | - | -380.11%(+574.1%) |
| Dec 2006 | -116.05%(-452.1%) | -56.39%(-345.8%) |
| Sept 2006 | - | 22.94%(+1.1%) |
| June 2006 | - | 22.68%(-2.2%) |
| Mar 2006 | - | 23.18%(-33.9%) |
| Dec 2005 | 32.96%(-45.0%) | 35.07%(+103.9%) |
| Sept 2005 | - | 17.20%(-65.3%) |
| June 2005 | - | 49.52%(-76.2%) |
| Mar 2005 | - | 207.69%(-133.5%) |
| Dec 2004 | 59.93%(-111.3%) | -619.08%(+86.9%) |
| Sept 2004 | - | -331.31%(-1.7%) |
| June 2004 | - | -336.92%(+3.4%) |
| Mar 2004 | - | -325.80%(+10.9%) |
| Dec 2003 | -529.17%(-18.3%) | -293.87%(+137.8%) |
| Sept 2003 | - | -123.59%(+15.3%) |
| June 2003 | - | -107.17%(+0.9%) |
| Mar 2003 | - | -106.20%(-12.7%) |
| Dec 2002 | -647.55%(-971.7%) | -121.62%(-44.6%) |
| Sept 2002 | - | -219.53%(-88.9%) |
| June 2002 | - | -1984.72%(-1728.2%) |
| Mar 2002 | - | 121.90%(+37.4%) |
| Dec 2001 | 74.29%(-43.4%) | 88.69%(-0.6%) |
| Sept 2001 | - | 89.23%(-21.8%) |
| June 2001 | - | 114.11%(-26.0%) |
| Mar 2001 | - | 154.16%(-38.0%) |
| Dec 2000 | 131.29%(-55.0%) | 248.79%(-34.9%) |
| Sept 2000 | - | 382.19%(+10.5%) |
| June 2000 | - | 345.76%(+10.2%) |
| Mar 2000 | - | 313.63%(+22.5%) |
| Dec 1999 | 291.87%(-128.3%) | 256.11%(-29.1%) |
| Sept 1999 | - | 361.37%(-62.4%) |
| June 1999 | - | 960.96%(-126.8%) |
| Mar 1999 | - | -3584.34%(+305.6%) |
| Dec 1998 | -1029.69%(+253.5%) | -883.81%(+14.6%) |
| Sept 1998 | - | -771.23%(+53.4%) |
| June 1998 | - | -502.73%(+24.7%) |
| Mar 1998 | - | -403.11%(+12.8%) |
| Dec 1997 | -291.28%(+144.4%) | -357.35%(+86.2%) |
| Sept 1997 | - | -191.87%(+4.7%) |
| June 1997 | - | -183.33%(+0.2%) |
| Mar 1997 | - | -183.02%(+4.0%) |
| Dec 1996 | -119.17%(-49.5%) | -175.94%(+8.2%) |
| Sept 1996 | - | -162.67%(+16.6%) |
| June 1996 | - | -139.57%(-42.3%) |
| Mar 1996 | - | -241.88%(+9.9%) |
| Dec 1995 | -236.03%(+129.1%) | -220.01%(+3.3%) |
| Sept 1995 | - | -212.92%(+0.5%) |
| June 1995 | - | -211.87%(+143.6%) |
| Mar 1995 | - | -86.96%(-1.0%) |
| Dec 1994 | -103.04% | -87.84%(+38.0%) |
| Sept 1994 | - | -63.65%(+43.3%) |
| June 1994 | - | -44.41%(+131.1%) |
| Mar 1994 | - | -19.22% |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual return on equity?
- What is the all time high annual ROE for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual ROE year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly return on equity?
- What is the all time high quarterly ROE for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly ROE year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual return on equity?
The current annual ROE of LGND is 8.03%
What is the all time high annual ROE for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual return on equity is 997.71%
What is Ligand Pharmaceuticals Incorporated annual ROE year-on-year change?
Over the past year, LGND annual return on equity has changed by +12.73% (+270.85%)
What is Ligand Pharmaceuticals Incorporated quarterly return on equity?
The current quarterly ROE of LGND is 5.97%
What is the all time high quarterly ROE for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly return on equity is 5291.62%
What is Ligand Pharmaceuticals Incorporated quarterly ROE year-on-year change?
Over the past year, LGND quarterly return on equity has changed by +3.54% (+145.68%)